Get my own profile
Public access
View all12 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyVerified email at bccancer.bc.ca
- Robert A. HoltHead of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency Distinguished ScientistVerified email at bcgsc.ca
- Darin A. WickDeeley Research Centre, BC Cancer AgencVerified email at wick.ca
- Katey SS EnfieldFrancis Crick Institute, London, UKVerified email at crick.ac.uk
- Wan L. LamBC Cancer Research Centre; University of British ColumbiaVerified email at bccrc.ca
- Julie S. NielsenLeader, Cell Manufacturing, BC Cancer's Immunotherapy ProgramVerified email at bccancer.bc.ca
- Scott Derek BrownResearch Associate, BC Cancer Research InstituteVerified email at bcgsc.ca
- john webbBritish Columbia Cancer Agency / Deeley Research CentreVerified email at bccrc.ca
- Erin A Marshall, PhDUniversity of British Columbia (BC Cancer Research Centre)Verified email at bccrc.ca
- Peter H WatsonBC CancerVerified email at bccancer.bc.ca
- Kwame Twumasi-BoatengTelix PharmaceuticalsVerified email at telixpharma.com
- David KroegerAssociate Director BD, Zymeworks Inc.Verified email at usask.ca
- Ewan A GibbSenior Scientist & Assistant ProfessorVerified email at ubc.ca
- RL WarrenGenome Sciences Centre, BC CancerVerified email at bcgsc.ca
- Nathaniel R WestGenentechVerified email at gene.com
- Mauro CastellarinResearch Associate, University of Pennsylvania, Center for Cellular ImmunotherapiesVerified email at pennmedicine.upenn.edu
- George CoukosUniversity Hospital of Lausanne, Ludwig Institute for Cancer ResearchVerified email at chuv.ch
Follow
Spencer D. Martin, MD PhD
Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British columbia
Verified email at vch.ca